CHRM5 and prostate adenocarcinoma: (B) According to Spearman’s p values, results indicated there was a significant (p < 0.05) positive correlation between EGFR expression and (a) CHRM1, (b) CHRM2, (c) CHRM3, (d) CHRM4, and (e) CHRM5 expression in PRAD.